← Back to Patent Explorer
US3899580A Expired / Lapsed US ⏱️ 0.0 years remaining

Anti-inflammatory topical gel

Assignee: Merck and Co Inc
•
Filing: 1974-05-08
•
Granted: 1975-08-12
•
Expires: 1994-05-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods and compositions for topical application of an antiinflammatory agent selected from the group consisting of 2''-(4pyridyl)-6,16 Alpha -dimethyl-11 Beta ,17 Alpha ,21trihydroxypregna-4,6-dieno(3,2-c)-pyrazol-20-one, dexamethasone alcohol, prednisolone alcohol, and hydrocortisone alcohol in a clear water-white gel vehicle.

Inventors

  • 👤 Joseph L O'neill
  • 👤 Joseph V Bondi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 23:05
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56; A61K31/58; A61K47/00; A61K47/06; A61K47/08; A61K47/10; A61K47/30; A61K47/36; A61K47/38; A61K9/00; A61K9/0012; A61K9/0014

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 95 words
A METHOD OF TREATING INFLAMMATION WHICH COMPRISES APPLYING TO THE SKIN A TOPICAL FORMULATION COMPRISING A THERAPEUTICALLY EFFECTIVE AMOUNT OF AN ANTI-INFLAMMATORY AGENT SELECTED FROM THE GROUP CONSISTING OF 2''-(4-PYRIDYL)-6,16ADIMETHYL-11B,17A,21-TRIHYDROXYPREGNA-4,6-DIENO-(3,2 -C)PYRAZOL-20-ONE, DEXAMETHASONE ALCOHOL PREDNISOLONE ALCOHOL AND HYDROCORTISONE ALCOHOL IN A CLEAR WATER-WHITE GEL CONSISTING OF 0.05 PERCENT BY WEIGHT OF DISODIUM EDETATE, FROM 8 TO 18 PERCENT BY WEIGHT OF WATER, FROM ABOUT 54 TO ABOUT 84 PERCENT BY WEIGHT OF A SOLVENT SELECTED FROM THE GROUP CONSISTING OF PROPYLENE GLYCOL AND MIXTURES THEREOF WITH ISOPROPYL ALCOHOL, AND 2.6 PERCENT BY WEIGHT OF HYDROXYPROPYL CELLULOSE.
Claim 2
Independent Claim 95 words
A METHOD OF TREATING INFLAMMATION WHICH COMPRISES APPLYING TO THE SKIN A TOPICAL FORMULATION COMPRISING A THERAPEUTICALLY EFFECTIVE AMOUNT OF AN ANTI-INFLAMMATORY AGENT SELECTED FROM THE GROUP CONSISTING OF 2''-(4-PYRIDYL)-6,16ADIMETHYL-11B,17A,21-TRIHYDROXYPREGNA-4,6-DIENO-(3,2 -C)PYRAZOL-20-ONE, DEXAMETHASONE ALCOHOL PREDNISOLONE ALCOHOL AND HYDROCORTISONE ALCOHOL IN A CLEAR WATER-WHITE GEL CONSISTING OF 0.05 PERCENT BY WEIGHT OF DISODIUM EDETATE, FROM 8 TO 18 PERCENT BY WEIGHT OF WATER, FROM ABOUT 54 TO ABOUT 84 PERCENT BY WEIGHT OF A SOLVENT SELECTED FROM THE GROUP CONSISTING OF PROPYLENE GLYCOL AND MIXTURES THEREOF WITH ISOPROPYL ALCOHOL, AND 2.6 PERCENT BY WEIGHT OF HYDROXYPROPYL CELLULOSE.
Claim 3
Dependent Claim 23 words
The method of claim 1 wherein the anti-inflammatory agent is 2''-(4-pyridyl)-6,16 Alpha -dimethyl-11 Beta ,17 Alpha ,21-trihydroxypregna-4,6-dieno-(3,2-c)-pyrazol-20-one, and the solvent is propylene glycol.
Claim 4
Dependent Claim 29 words
The method of claim 1 wherein the anti-inflammatory agent is 2''-(4-pyridyl)-6,16 Alpha -dimethyl-11 Beta ,17 Alpha ,21-trihydroxypregna-4,6-dieno-(3,2-c)-pyrazol-20-one, and the solvent is a mixture of isopropyl alcohol and propylene glycol.
Claim 5
Dependent Claim 21 words
The method of claim 3 wherein the isopropyl alcohol and propylene glycol solvent mixture is at a 0.5:1 to 0.6:1 ratio.
Claim 6
Dependent Claim 93 words
A topical formulation for treating inflammation which comprises a therapeutically effective amount of an anti-inflammatory agent selected from the group consisting of 2''-(4-pyridyl)-6,16 Alpha -dimethyl-11 Beta ,17 Alpha ,21-trihydroxypregna-4,6-dieno-(3,2-c)-pyrazol-20-one, dexamethasone alcohol, prednisolone alcohol and hydrocortisone alcohol in a clear water-white gel consisting of 0.05 percent by weight of disodium edetate, from 8 to 18 percent by weight of water, from about 54 to about 84 percent by weight of a solvent selected from the group consisting of propylene glycol and mixtures thereof with isopropyl alcohol, and 2.6 percent by weight of hydroxypropyl cellulose.
Claim 7
Dependent Claim 93 words
A topical formulation for treating inflammation which comprises a therapeutically effective amount of an anti-inflammatory agent selected from the group consisting of 2''-(4-pyridyl)-6,16 Alpha -dimethyl-11 Beta ,17 Alpha ,21-trihydroxypregna-4,6-dieno-(3,2-c)-pyrazol-20-one, dexamethasone alcohol, prednisolone alcohol and hydrocortisone alcohol in a clear water-white gel consisting of 0.05 percent by weight of disodium edetate, from 8 to 18 percent by weight of water, from about 54 to about 84 percent by weight of a solvent selected from the group consisting of propylene glycol and mixtures thereof with isopropyl alcohol, and 2.6 percent by weight of hydroxypropyl cellulose.
Claim 8
Dependent Claim 24 words
The composition of claim 5 wherein the anti-inflammatory agent is 2''-4(pyridyl)-6,16 Alpha -dimethyL-11 Beta ,17 Alpha , 21-trihydroxypregna-4,6-dieno-(3,2-c)-pyrazol-20-one, and the solvent is propylene glycol.
Claim 9
Dependent Claim 30 words
The composition of claim 5 wherein the anti-inflammatory agent is 2''-4(pyridyl)-6,16 Alpha -dimethyl-11 Beta ,17 Alpha , 21-trihydroxypregna-4,6-dieno-(3,2-c)-pryazol-20-one, and the solvent is a mixture of isopropyl alcohol and propylene glycol.
Claim 10
Dependent Claim 21 words
The composition of claim 7 wherein the isopropyl alcohol and propylene glycol solvent mixture is at a 0.5:1 to 0.6:1 ratio.

References Cited (Backward Citations)

US3067194A Cited
US3485915A Cited
US3749773A Cited
US3856954A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-08-11 1979-02-10 1979-08-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-08-11 1983-02-10 1983-08-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-08-11 1987-02-10 1987-08-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag